Lead Product(s) : Isopropyl Unoprostone
Therapeutic Area : Genetic Disease
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Phase III Efficacy and Safety Clinical Study of UF-021 for Treatment of Retinitis Pigmentosa
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
February 08, 2013
Lead Product(s) : Isopropyl Unoprostone
Therapeutic Area : Genetic Disease
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Isopropyl Unoprostone
Therapeutic Area : Ophthalmology
Study Phase : Phase II
Sponsor : Sucampo Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
June 23, 2011
Lead Product(s) : Isopropyl Unoprostone
Therapeutic Area : Ophthalmology
Highest Development Status : Phase II
Sponsor : Sucampo Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
